Semiconductor Manufacturing International Corporation Announces First 45-Nanometer Silicon Success

Semiconductor Manufacturing International Corporation ("SMIC", NYSE: SMI and SEHK: 0981.HK) today announced its first 45-nanometer yield lot, signifying a working 45nm process. This first silicon success comes less than one year after SMIC signed an agreement with International Business Machines ("IBM") to license its low- power and high-performance bulk CMOS technologies in December 2007.

Over the past 11 months, SMIC has put manufacturing equipment in place, built an expert team to work with IBM to ensure effective technology transfer, and begun running technology qualification vehicles. The first full-flow lot consisted of 300mm wafers that were run under testing conditions set forth by IBM, and achieved strong yields. "Lead customers are pleased with the progress made by SMIC's 45nm project team and we appreciate the excellent technical support from IBM's Systems and Technology Group," said Dr. Robert Tsu, SMIC's 45nm project leader and Associate Vice President of Logic Technology. "This achievement has marked the first major milestone of the project and paves a way to provide an IBM-licensed technology and SMIC wafer foundry service to our customers."

This milestone, completed ahead of schedule, enhances SMIC's position as the advanced logic technology leader in China. SMIC has agreements in place with its lead customers for 45nm, and plans to meet these customers' production schedules for 2009. Complementing SMIC's ongoing in-house research and development progress, this 45nm technology is supported with a proven SPICE model, allowing for smooth design-ins and enabling customers to plan for early time-to-market.

The 45nm bulk CMOS technology licensed from IBM has many applications, including mobile devices, such as handsets integrated with 3G baseband, GPS, and multimedia processors. The technology also can support graphic, network, storage, and general consumer devices.

"The completion of our first 45nm yield lot is an exciting and encouraging result," said Chris Chi, Senior Vice President of Marketing and Sales. "It verifies the IBM-licensed technology, substantiates our strategic decision to concentrate on logic technologies, and positions SMIC to offer leading edge, time-to-market 45nm foundry solutions to both design and systems houses. And in making this step ahead of schedule, it also proves SMIC's ability to develop technology under rigorous time constraints."

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Semiconductor Manufacturing International Corporation (SMIC). (2019, February 15). Semiconductor Manufacturing International Corporation Announces First 45-Nanometer Silicon Success. AZoNano. Retrieved on November 06, 2024 from https://www.azonano.com/news.aspx?newsID=9069.

  • MLA

    Semiconductor Manufacturing International Corporation (SMIC). "Semiconductor Manufacturing International Corporation Announces First 45-Nanometer Silicon Success". AZoNano. 06 November 2024. <https://www.azonano.com/news.aspx?newsID=9069>.

  • Chicago

    Semiconductor Manufacturing International Corporation (SMIC). "Semiconductor Manufacturing International Corporation Announces First 45-Nanometer Silicon Success". AZoNano. https://www.azonano.com/news.aspx?newsID=9069. (accessed November 06, 2024).

  • Harvard

    Semiconductor Manufacturing International Corporation (SMIC). 2019. Semiconductor Manufacturing International Corporation Announces First 45-Nanometer Silicon Success. AZoNano, viewed 06 November 2024, https://www.azonano.com/news.aspx?newsID=9069.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.